• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由单个微小RNA多顺反子表达的多个小干扰RNA对HIV-1的抑制作用。

Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron.

作者信息

Liu Ying Poi, Haasnoot Joost, ter Brake Olivier, Berkhout Ben, Konstantinova Pavlina

机构信息

Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.

出版信息

Nucleic Acids Res. 2008 May;36(9):2811-24. doi: 10.1093/nar/gkn109. Epub 2008 Mar 16.

DOI:10.1093/nar/gkn109
PMID:18346971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2396423/
Abstract

RNA interference (RNAi) is a powerful approach to inhibit human immunodeficiency virus type 1 (HIV-1) replication. However, HIV-1 can escape from RNAi-mediated antiviral therapy by selection of mutations in the targeted sequence. To prevent viral escape, multiple small interfering RNAs (siRNAs) against conserved viral sequences should be combined. Ideally, these RNA inhibitors should be expressed simultaneously from a single transgene transcript. In this study, we tested a multiplex microRNA (miRNA) expression strategy by inserting multiple effective anti-HIV siRNA sequences in the miRNA polycistron mir-17-92. Individual anti-HIV miRNAs that resemble the natural miRNA structures were optimized by varying the siRNA position in the hairpin stem to obtain maximal effectiveness against luciferase reporters and HIV-1. We show that an antiviral miRNA construct can have a greater intrinsic inhibitory activity than a conventional short hairpin (shRNA) construct. When combined in a polycistron setting, the silencing activity of an individual miRNA is strongly boosted. We demonstrate that HIV-1 replication can be efficiently inhibited by simultaneous expression of four antiviral siRNAs from the polycistronic miRNA transcript. These combined results indicate that a multiplex miRNA strategy may be a promising therapeutic approach to attack escape-prone viral pathogens.

摘要

RNA干扰(RNAi)是一种抑制人类免疫缺陷病毒1型(HIV-1)复制的有效方法。然而,HIV-1可通过在靶向序列中选择突变来逃避RNAi介导的抗病毒治疗。为防止病毒逃逸,应将针对保守病毒序列的多个小干扰RNA(siRNA)联合使用。理想情况下,这些RNA抑制剂应从单个转基因转录本中同时表达。在本研究中,我们通过在miRNA多顺反子mir-17-92中插入多个有效的抗HIV siRNA序列,测试了一种多重微小RNA(miRNA)表达策略。通过改变发夹茎中siRNA的位置,优化了类似于天然miRNA结构的单个抗HIV miRNA,以获得对荧光素酶报告基因和HIV-1的最大抑制效果。我们表明,抗病毒miRNA构建体比传统短发夹(shRNA)构建体具有更强的内在抑制活性。当在多顺反子环境中联合使用时,单个miRNA的沉默活性会大大增强。我们证明,从多顺反子miRNA转录本中同时表达四种抗病毒siRNA可有效抑制HIV-1复制。这些综合结果表明,多重miRNA策略可能是一种有前途的治疗方法,可用于对抗易逃逸的病毒病原体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/63ac041482bd/gkn109f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/2739a3797c59/gkn109f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/b3fd3d3b91fe/gkn109f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/d07c7206ffb1/gkn109f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/a6f95f9f9da8/gkn109f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/a8e9fd9de645/gkn109f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/d4bc8e306164/gkn109f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/63ac041482bd/gkn109f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/2739a3797c59/gkn109f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/b3fd3d3b91fe/gkn109f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/d07c7206ffb1/gkn109f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/a6f95f9f9da8/gkn109f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/a8e9fd9de645/gkn109f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/d4bc8e306164/gkn109f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ff/2396423/63ac041482bd/gkn109f7.jpg

相似文献

1
Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron.由单个微小RNA多顺反子表达的多个小干扰RNA对HIV-1的抑制作用。
Nucleic Acids Res. 2008 May;36(9):2811-24. doi: 10.1093/nar/gkn109. Epub 2008 Mar 16.
2
The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA.从单个由U6 RNA聚合酶III表达的长发夹RNA产生三种独立的抗HIV-1 siRNA的效果。
PLoS One. 2008 Jul 2;3(7):e2602. doi: 10.1371/journal.pone.0002602.
3
Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.使用微小RNA设计的发夹增强HIV-1特异性小干扰RNA的基因沉默作用。
Nucleic Acids Res. 2004 Feb 13;32(3):1154-8. doi: 10.1093/nar/gkh278. Print 2004.
4
Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct.人工多顺反子 miRNA 构建体高效抑制 HIV-1 复制。
Virol J. 2012 Jun 18;9:118. doi: 10.1186/1743-422X-9-118.
5
Design of extended short hairpin RNAs for HIV-1 inhibition.用于抑制HIV-1的延长型短发夹RNA的设计
Nucleic Acids Res. 2007;35(17):5683-93. doi: 10.1093/nar/gkm596. Epub 2007 Aug 21.
6
A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.一种用于同时抑制和表达蛋白质编码序列的多重miRNA和转基因表达平台。
Mol Biosyst. 2016 Jan;12(1):295-312. doi: 10.1039/c5mb00506j.
7
Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.内源性 MCM7 microRNA 簇作为一种新型平台,用于组合 HIV-1 基因治疗中的小干扰 RNA 和核仁 RNA。
Hum Gene Ther. 2012 Nov;23(11):1200-8. doi: 10.1089/hum.2012.011. Epub 2012 Sep 18.
8
Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors.从一个包含两个相邻长发夹 RNA 前体的单个 Pol III 生成的转录本中衍生出四个功能性抗 HIV siRNA。
Nucleic Acids Res. 2010 Oct;38(19):6652-63. doi: 10.1093/nar/gkq460. Epub 2010 Jun 4.
9
Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.形成三链体的微小RNA与HIV-1前病毒形成稳定复合物并抑制其复制。
Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):532-45. doi: 10.1097/PAI.0b013e3181e1ef6a.
10
Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters.用从RNA聚合酶II启动子表达的设计性微小RNA抑制HIV-1复制。
Gene Ther. 2007 Nov;14(21):1503-12. doi: 10.1038/sj.gt.3303011. Epub 2007 Sep 6.

引用本文的文献

1
Therapeutic Approaches of Viral Gene Silencing by Small Interfering RNA: Strategies to Prevent the Emergence of Antiviral Resistant Escape Mutants.小干扰RNA介导的病毒基因沉默治疗方法:预防抗病毒耐药逃逸突变体出现的策略
Pharmaceuticals (Basel). 2025 Jul 1;18(7):987. doi: 10.3390/ph18070987.
2
Allogeneic CART progress: platforms, current progress and limitations.同种异体嵌合抗原受体T细胞疗法的进展:平台、当前进展及局限性
Front Immunol. 2025 Jun 12;16:1557157. doi: 10.3389/fimmu.2025.1557157. eCollection 2025.
3
Therapeutic Applications of Poly-miRNAs and miRNA Sponges.

本文引用的文献

1
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition.用于多种shRNA表达和持久抑制HIV-1的慢病毒载体设计
Mol Ther. 2008 Mar;16(3):557-564. doi: 10.1038/sj.mt.6300382. Epub 2016 Dec 8.
2
A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs.一种通过RNA干扰抑制HIV-1的新方法:用第二代小干扰RNA对抗病毒逃逸
J RNAi Gene Silencing. 2005 Oct 14;1(2):56-65.
3
RNA interference against viruses: strike and counterstrike.针对病毒的RNA干扰:攻击与反击
多miRNA和miRNA海绵的治疗应用
Int J Mol Sci. 2025 May 9;26(10):4535. doi: 10.3390/ijms26104535.
4
Circadian Clock Gene Bmal1: A Molecular Bridge from AKI to CKD.生物钟基因Bmal1:从急性肾损伤到慢性肾病的分子桥梁
Biomolecules. 2025 Jan 7;15(1):77. doi: 10.3390/biom15010077.
5
High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination.两种小干扰RNA组合在新冠病毒临床前模型中的高抗性屏障和预防性保护作用
Nucleic Acids Res. 2025 Jan 7;53(1). doi: 10.1093/nar/gkae1195.
6
Engineering strategies to safely drive CAR T-cells into the future.工程化策略助力 CAR T 细胞安全迈入未来。
Front Immunol. 2024 Jun 19;15:1411393. doi: 10.3389/fimmu.2024.1411393. eCollection 2024.
7
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?同种异体嵌合抗原受体 T 细胞治疗技术:是否兑现了承诺?
Cells. 2024 Jan 12;13(2):146. doi: 10.3390/cells13020146.
8
Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform.使用嵌合微小RNA簇平台通过基于短发夹RNA高效敲低多个靶基因用于细胞治疗
Mol Ther Nucleic Acids. 2023 Sep 20;34:102038. doi: 10.1016/j.omtn.2023.102038. eCollection 2023 Dec 12.
9
Multiplexed shRNA-miRs as a candidate for anti HIV-1 therapy: strategies, challenges, and future potential.多重短发夹RNA-微小RNA作为抗HIV-1治疗的候选物:策略、挑战及未来潜力
J Genet Eng Biotechnol. 2022 Dec 28;20(1):172. doi: 10.1186/s43141-022-00451-z.
10
Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications.红细胞系特异性慢病毒 RNAi 载体,适用于分子功能研究和治疗应用。
Sci Rep. 2022 Aug 18;12(1):14033. doi: 10.1038/s41598-022-13783-0.
Nat Biotechnol. 2007 Dec;25(12):1435-43. doi: 10.1038/nbt1369.
4
Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters.用从RNA聚合酶II启动子表达的设计性微小RNA抑制HIV-1复制。
Gene Ther. 2007 Nov;14(21):1503-12. doi: 10.1038/sj.gt.3303011. Epub 2007 Sep 6.
5
Design of extended short hairpin RNAs for HIV-1 inhibition.用于抑制HIV-1的延长型短发夹RNA的设计
Nucleic Acids Res. 2007;35(17):5683-93. doi: 10.1093/nar/gkm596. Epub 2007 Aug 21.
6
Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.小干扰RNA的组合递送通过选择性掺入RNA诱导沉默复合体(RISC)而降低RNA干扰(RNAi)功效。
Nucleic Acids Res. 2007;35(15):5154-64. doi: 10.1093/nar/gkm543. Epub 2007 Jul 26.
7
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.携带抗HIV短发夹RNA的慢病毒载体:问题与解决方案
J Gene Med. 2007 Sep;9(9):743-50. doi: 10.1002/jgm.1078.
8
Artificial microRNA-mediated virus resistance in plants.人工微小RNA介导的植物抗病毒性
J Virol. 2007 Jun;81(12):6690-9. doi: 10.1128/JVI.02457-06. Epub 2007 Mar 7.
9
Expression of artificial microRNAs in transgenic Arabidopsis thaliana confers virus resistance.人工微小RNA在转基因拟南芥中的表达赋予病毒抗性。
Nat Biotechnol. 2006 Nov;24(11):1420-8. doi: 10.1038/nbt1255. Epub 2006 Oct 22.
10
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients.靶向将WASp表达导入造血细胞的慢病毒载体可有效转导并校正WAS患者的细胞。
Gene Ther. 2007 Mar;14(5):415-28. doi: 10.1038/sj.gt.3302863. Epub 2006 Oct 19.